Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: A randomised placebo controlled double blind 52 weeks clinical trial

H. R.M. Peeters, M. Jongen-Lavrencic, G. Vreugdenhil, A. J.G. Swaak*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: A randomised placebo controlled double blind 52 weeks clinical trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science